Using the same dataset from TCGA we evaluated the prognostic value of Myo1g in the renal cancer patients and found a significant difference (p < 0.0001) indicating that high Myo1g expression correlate with poor survival Figure 2C. Here, MYO1G is linked to renal carcinoma.